Cutera, Inc. (NASDAQ:CUTR) was the recipient of a significant increase in short interest in December. As of December 29th, there was short interest totalling 681,844 shares, an increase of 33.4% from the December 15th total of 511,315 shares. Approximately 5.1% of the company’s stock are sold short. Based on an average daily trading volume, of 212,563 shares, the days-to-cover ratio is currently 3.2 days.
Shares of Cutera (CUTR) opened at $50.35 on Friday. The company has a market cap of $683.74, a price-to-earnings ratio of 64.55, a PEG ratio of 1.47 and a beta of 0.52. Cutera has a 1 year low of $18.00 and a 1 year high of $50.50.
Cutera (NASDAQ:CUTR) last announced its quarterly earnings data on Tuesday, November 7th. The medical device company reported $0.42 EPS for the quarter, topping the Zacks’ consensus estimate of $0.08 by $0.34. The business had revenue of $38.17 million for the quarter, compared to analyst estimates of $34.82 million. Cutera had a net margin of 7.99% and a return on equity of 18.73%. The firm’s revenue for the quarter was up 26.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.12 earnings per share. equities analysts anticipate that Cutera will post 0.55 earnings per share for the current fiscal year.
In other Cutera news, Director Timothy J. Oshea sold 4,000 shares of Cutera stock in a transaction that occurred on Monday, October 16th. The shares were sold at an average price of $39.21, for a total value of $156,840.00. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider James A. Reinstein sold 7,175 shares of Cutera stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $45.35, for a total transaction of $325,386.25. Following the completion of the transaction, the insider now directly owns 132,284 shares in the company, valued at approximately $5,999,079.40. The disclosure for this sale can be found here. In the last ninety days, insiders sold 37,968 shares of company stock worth $1,676,086. Insiders own 11.60% of the company’s stock.
Hedge funds have recently made changes to their positions in the company. Parallel Advisors LLC bought a new stake in Cutera during the third quarter worth $117,000. Legal & General Group Plc raised its position in Cutera by 69.6% during the third quarter. Legal & General Group Plc now owns 3,600 shares of the medical device company’s stock worth $149,000 after acquiring an additional 1,477 shares in the last quarter. Greenwood Capital Associates LLC bought a new stake in Cutera during the third quarter worth $210,000. Dynamic Technology Lab Private Ltd bought a new stake in Cutera during the third quarter worth $264,000. Finally, Mackenzie Financial Corp bought a new stake in Cutera during the third quarter worth $277,000. 87.64% of the stock is currently owned by institutional investors and hedge funds.
Cutera Company Profile
Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.
Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with our FREE daily email newsletter.